Navigation Links
A trial to find out the effectiveness of biocides against Vespa velutina
Date:4/16/2013

The Monitoring Committee for the Asian hornet, the Vespa velutina, in which the Government of the Basque Autonomous Community (region), the Charter Provincial Councils, the Beekeeping sector and Neiker-Tecnalia are working together, will be taking steps aimed at controlling the Vespa velutina populations and minimizing their impact. This type of hornet is an invasive species from France that preys on bees and devastates beehives.

The Vespa velutina Monitoring Committee, which has been fighting to control this pest in the Basque Autonomous Community, has agreed to develop, through Neiker-Tecnalia, a controlled trial to assess the potential effectiveness on this insect of biocides tested in Chile for the Vspula germnica. This process will be carried out through the placing and controlled monitoring of baits, thus seeking to minimize the effects on other insect populations, birds and vertebrates.

Another of the steps will make it possible to find out the effect the Asian hornet is having on the viability and production of beehives by analysing the location of the Vespa velutina nests and determining its expansion and advances.

The Basque Government has initially earmarked 45,000 euros to fund these steps and has proposed action protocols with each of the parties involved in order to achieve progress.


'/>"/>

Contact: Irati Kortabitarte
i.kortabitarte@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Page: 1

Related biology news :

1. Sea level rise: Jeopardy for terrestrial biodiversity on islands
2. Mummy CT scans show preindustrial hunter gatherers had clogged arteries
3. Human trials for Streptococcus A vaccine
4. Manchester patients take part in pioneering heart attack blood test trial
5. MSU launches groundbreaking drug trial in Africa
6. Major clinical trial finds no link between genetic risk factors and 2 top wet AMD treatments
7. VIB applies for second poplar field trial
8. Canada launches first gene therapy trial for Fabry disease
9. £35 million to support research for vital industrial sector
10. New marker of drug response may speed pace of lung cancer prevention trials
11. New tuberculosis drug trial begins in South Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016 Research and Markets has announced the ... report to their offering. The ... to grow at a CAGR of 12.28% during the period ... an in-depth market analysis with inputs from industry experts. The report ... years. The report also includes a discussion of the key vendors ...
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, ... congestive heart failure and type 2 diabetes, announced ... a novel adeno-associated virus (AAV) vector developed in ... M.D., Ph.D., at Stanford University. The company plans ... paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... light to control cells — optogenetics — is key to exciting advances in ... the art, spatially patterned light projected via free-space optics stimulates small, transparent organisms ...
(Date:12/8/2016)... , December 8, 2016 ... für Molekulargenetik, erweitert seine Palette an anpassbaren SureSeq™ ... Custom FH Panels, das ein schnelles und kostengünstiges ... Das Panel bietet eine Erkennung von Einzel-Nukleotid-Variationen (Single ... mit einem einzigen kleinen Panel und ermöglicht eine ...
(Date:12/8/2016)... Dec. 8, 2016  Anaconda BioMed S.L., a pre-clinical ... the next generation neuro-thrombectomy system for the treatment of ... G. Jovin, MD to join its Scientific Advisory Board ... strategic network of scientific and clinical experts to Anaconda ... the ANCD BRAIN ® to its clinical phase. ...
Breaking Biology Technology: